Pfizer COVID-19 Vaccine Reaches 90% Effectiveness in Early Analysis
A new vaccine developed by Pfizer and the German biotechnology firm BioNTech was more than 90% effective at protecting people from COVID-19.
COVID19
NIH: Hydroxychloroquine Not Effective for COVID-19
The ORCHID trial was halted in June 2020 after it was determined that hydroxychloroquine was unlikely to benefit hospitalized patients.
Interim Data Show COVID-19 Vaccine Candidate mRNA-1273 Nearly 95% Effective
A phase 3 trial evaluating the vaccine candidate mRNA-1273 against COVID-19 met its primary efficacy end point in the first interim analysis.
Addition of Azithromycin to Hydroxychloroquine Does Not Improve Outcomes in Severe COVID-19
Study authors assessed whether azithromycin in addition to a hydroxychloroquine regimen shows positive results in clinical improvement or mortality reduction in patients hospitalized with severe COVID-19.
Healthcare Providers Recognize Potential Benefits of Telemedicine in Pediatric Rheumatology During the COVID-19 Pandemic
During the COVID-19 pandemic, healthcare teams have realized the potential of telemedicine in pediatric rheumatology practices.
Assessing the Effect of Antimalarial Drug Shortages in Rheumatic Disease During the COVID-19 Pandemic
The COVID-19 Global Rheumatology Alliance Patient Experience Survey was used to assess the effect of antimalarial drug shortages during the COVID-19 pandemic.
Neurologic Manifestations of COVID-19 May Involve Cytokine Release Syndrome
Neurologic disturbances in patients with coronavirus disease 2019 were accompanied by evidence of cytokine release syndrome.
COVID-19 Vaccine Allocation: Ethical Concerns, Practical Challenges
In the event of a likely scarcity of COVID-19 vaccines, a framework must be developed to inform who should get priority.
Convalescent Plasma Has Limited Benefit for Moderate COVID-19
For patients with moderate COVID-19, convalescent plasma does not reduce progression to severe COVID-19 or mortality.
COVID-19 Pandemic Challenges Osteoporosis Management
The COVID-19 pandemic may have negatively impacted osteoporosis management.
-
Loading...
-
Loading...
Next post in Osteoporosis
